Senaste uppdateringen :
19/11/2024
Antiinflammatoriskt medel   Ketorolac tromethamine  
injektion
Lösningars stabilitet Stabilitet i blandningar Faktorer som påverkar stabiliteten Kompatibilitet Administreringssätt Hänvisningar pdf
   Molekylstruktur  

Varunamn   Varunamn     

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Bedoral Sydafrikanska republiken
Ketorolac trometamol Storbritannien
Lixidol Italien
Taradyl Belgien
Toradol Danmark, Finland, Italien, Norge, Spanien, Storbritannien, Sverige
Hänvisningar   injektion   Hänvisningar : Ketorolac tromethamine  
Typ Publikation
59 tidningen Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
216 tidningen Huang E, Anderson RP.
Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine.
Am J Hosp Pharm 1994 ; 51: 2963.
228 tidningen Mendenhall A, Hoyt DB.
Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate.
Am J Hosp Pharm 1994 ; 51: 2964.
299 tidningen Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
451 tidningen Das Gupta V, Maswoswe J, Bailey RE.
Stability of ketorolac tromethamine in 5% dextrose injection and 0.9% sodium chloride injections.
Int J Pharm Compound 1997 ; 1: 206-207.
469 tidningen Floy BJ, Royko CJ, Fleitman JS.
Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets.
Am J Hosp Pharm 1990 ; 47: 1097-1100.
476 tidningen Knapp AJ, Mauro VF, Alexander KS.
Incompatibility of ketorolac tromethamine with selected postoperative drugs.
Am J Hosp Pharm 1992 ; 49: 2960-2962.
1634 tidningen Shi A, Walker SE, Law S.
Stability of ketorolac tromethamine in IV solutions and waste reduction.
Can J Hosp Pharm 2000 ; 53: 263-269.
1712 tidningen Trissel LA, Saenz CA.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 230-233.
1721 tidningen Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1800 tidningen Voytilla KL, Tyler LS, Rusho WJ.
Visual compatibility of azithromycin with 24 commonly used drugs during simulated Y-site delivery.
Am J Health-Syst Pharm 2002 ; 59: 853-855.
1803 tidningen Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.
Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2003 ; 60: 80-85.
1859 tidningen Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G.
Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy.
Il Farmaco 2002 ; 57: 925-930.
1974 tidningen Chandler SW, Trissel LA, Weinstein SM
Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility.
J Pain Symptom Manage 1996 ; 12, 3: 168-171.
2015 tidningen Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.
Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine.
Ann Pharmacotherapy 2005 39: 1654-1658.
2124 tidningen Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L.
Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C.
EJHP Science 2006 ; 12, 4: 72-75.
2166 tidningen Nassr S, Dubuc MC, Lavoie P, Brazier JL.
HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine.
J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.
3159 tidningen Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z.
Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution.
Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.
3169 tidningen Raffaeli W, Pari G, Visani L et al.
Experimentation about precipitation of pharmacological association: morphine and ketorolac.
Pain Clinic 1999 ; 11: 213-216.
3374 tidningen Smith R.P.R, Jones M.
Precipitation in Manchester: ketorolac/cyclizine
Anaesthesia 2001 ; 56: 494-495.
3470 tidningen Destro M, Ottolini L, Vicentini L, Boschetti S.
Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care.
Support Care Cancer 2012 ; 20: 2501-2509.
3571 tidningen Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.
Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration.
Hosp Pharm 2014 ; 49, 1: 42-47.
3593 Laboratorium Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics
Beacon Pharmaceuticals 2011
3601 Laboratorium Cisatracurium Actavis - Résumé des Caractéristiques du Produit
Actavis 2012
4433 tidningen Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K.
Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications
Clin Ther 2020 ; 42, 3: 475-485.
4435 tidningen Hanifah S, Nugroho B.H, Chabib L.
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
4828 tidningen Weeks A.L, Sotos J, Woolsey B, Johnston W.M, Cornelius B.W.
The Physical Compatibility of Glycopyrrolate and Rocuronium.
Anesth Prog 2023 ;70(2):53-57.

  Mentions Légales